Catalyst Pharmaceuticals (CPRX) Earnings Date & Reports

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

CPRX is expected to report earnings to fall 6.00% to 46 cents per share on August 12

Catalyst Pharmaceuticals CPRX Stock Earnings Reports

Q2'26

Est.

$0.47

Q1'26

Beat

by $0.06

Q4'25

Beat

by $0.37

Q3'25

Beat

by $0.35

Q2'25

Beat

by $0.29

The last earnings report on May 11 showed earnings per share of 50 cents, beating the estimate of 43 cents. With 684.64K shares outstanding, the current market capitalization sits at 3.83B.

View a ticker or compare two or three

Compare

CPRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CPRX